CJC-1295 without DAC: 5mg & 10mg Vials

CJC-1295 without DAC is a modified GHRH analogue studied in Australian preclinical research for its extended half-life and sustained growth hormone release profile. Australian endocrinology laboratories investigate GHRH receptor activation kinetics, pulsatile GH secretion patterns, and downstream IGF-1 modulation in controlled research settings.

No. CJC-1295 without DAC is strictly for laboratory research only. It is not intended for human consumption, therapeutic use, performance enhancement, or diagnostic procedures. All Australian purchasers must confirm legitimate research intent.

Refer to product documentation for specific storage guidance. In general, store lyophilised CJC-1295 without DAC in a freezer. After reconstitution with bacteriostatic water, refrigerate and follow the usage timeframe in the product documentation. Protect vials from light, moisture, and temperature fluctuation. Always follow institutional laboratory handling protocols.

Availability varies by product and batch. Where independent testing is complete, batch-specific Certificates of Analysis are available on request.

Dispatched within 1–3 business days from our international fulfilment partners in temperature-protected packaging. Estimated delivery is 5–9 days from order, processing included, express with a carrier tracking number. Free over $700 AUD. Every order ships express with a carrier tracking number emailed on dispatch. Trial vials are faster: they ship from domestic stock via Australia Post Express, same-day dispatch before 3 PM AEST, arriving in 2–3 business days.